美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA212826"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
67184-0535-1 67184-0535 HUMAN PRESCRIPTION DRUG Decitabine decitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20210412 N/A ANDA ANDA212826 Qilu Pharmaceutical Co., Ltd. DECITABINE 50 mg/20mL 1 VIAL in 1 CARTON (67184-0535-1) / 20 mL in 1 VIAL
25021-219-20 25021-219 HUMAN PRESCRIPTION DRUG Decitabine Decitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20231101 N/A ANDA ANDA212826 Sagent Pharmaceuticals DECITABINE 50 mg/20mL 1 VIAL in 1 CARTON (25021-219-20) / 20 mL in 1 VIAL
68001-618-37 68001-618 HUMAN PRESCRIPTION DRUG Decitabine Decitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20240503 N/A ANDA ANDA212826 BluePoint Laboratories DECITABINE 50 mg/20mL 1 VIAL in 1 CARTON (68001-618-37) / 20 mL in 1 VIAL
70860-219-20 70860-219 HUMAN PRESCRIPTION DRUG Decitabine decitabine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20210815 20241231 ANDA ANDA212826 Athenex Pharmaceutical Division, LLC. DECITABINE 50 mg/20mL 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-219-20) / 20 mL in 1 VIAL, SINGLE-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase